Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: Rituximab may be the right choice?

Autoimmunity

Volumn 45, Issue 4, 2012, Pages 304-309

  Szilasi, Mária ^a   Mátyus, János ^a   File, Ibolya ^a   Szücs, Gabriella ^a   Rákóczi, Éva ^a   Pfliegler, György ^a   Szabó, Zoltán ^a   Végh, Edit ^a   Szekanecz, Zoltán ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

ANCA associated vasculitis; Churg Strauss syndrome; microscopic polyangiitis; Rheumatoid arthritis; rituximab; Wegener's granulomatosis

Indexed keywords

ADALIMUMAB; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; SALAZOSULFAPYRIDINE; TUBERCULOSTATIC AGENT; VORICONAZOLE;

AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; BRAIN HEMORRHAGE; CASE REPORT; CHURG STRAUSS SYNDROME; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER ABSCESS; LOW DRUG DOSE; LUNG LESION; MALE; MICROSCOPIC POLYANGIITIS; MONOTHERAPY; PLASMAPHERESIS; RHEUMATOID ARTHRITIS; STROKE; THROMBOCYTOPENIA; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ARTHRITIS, RHEUMATOID; CHURG-STRAUSS SYNDROME; FEMALE; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; SYNDROME; WEGENER GRANULOMATOSIS;

EID: 84859872541     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.677078     Document Type: Article

References (33)

1. Pai S, Panda M. Limited Wegener's granulomatosis presenting as lung nodules in a patient with rheumatoid arthritis: a case report. Cases J 2008;1(1):417.
2. Pritchard MH. Wegener's granulomatosis presenting as theumatoid arthritis (two cases). Proc R Soc Med 1976; 69(7):501-504. (Pubitemid 8116373)
3. Svirskii AA, Potapenkov MA, Shchipulin PP, Kharitonov VM, Zelenin VS. [Wegener's granulomatosis in a patient with rheumatoid arthritis]. Lik Sprava 1994;(2):92-94.
4. Ohashi H, Itoh M, Ogawa N, Sudo Y, Endo S, Okugawa T, et al. Wegener's granulomatosis in a patient with a rheumatoid arthritis. Intern Med 1992;31(9):1128-1131. (Pubitemid 23012648)
5. Sturrock RD, Ratnesar P. Wegener's granulomatosis occurring in a patient with pre-existing rheumatoid arthritis. Br J Clin Pract 1974;28(5):183-184.
6. Chinoy H, McKenna F. Wegener's granulomatosis and rheumatoid arthritis overlap. Rheumatology (Oxford) 2002; 41(5):588-589. (Pubitemid 34567193)
7. Douglas G, Bird K, Flume P, Silver R, Bolster M. Wegener's granulomatosis in patients with rheumatoid arthritis. J Rheumatol 2003;30(9):2064-2069. (Pubitemid 37075563)
8. Palomar R, Castaneda O, Rodrigo E, Ruiz San-Millan JC, Martin Gago J, Morales P, et al. [Microscopic polyangiitis in a patient with rheumatoid arthritis]. Nefrologia 2005;25(4): 438-441.
9. Ortiz-Santamaria V, Serra A, Teixido J, Olive A. [Rheumatoid arthritis associated with microscopic polyangiitis]. Med Clin (Barc) 2000;114(20):793-794.
10. Soubrier M, Le Seaux S, Dubost JJ, Mizony MH, Ristori JM, Bussiere JL. [Rheumatoid arthritis preceding microscopic polyangitis. Report of two cases]. Rev Med Intern 2000;21(1): 78-82.
11. Steuer A, Palmer A, Colaco CB. A patient with rheumatoid arthritis and microscopic polyarteritis. Br J Rheumatol 1995; 34(12):1185-1186. (Pubitemid 26055345)
12. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33(8):1101-1107. (Pubitemid 20273294)
13. Yorioka N, Taniguchi Y, Amimoto D, Miyata H, Yamakido M, Taguchi T. Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis. Am J Nephrol 1999;19(4):527-529. (Pubitemid 29397087)
14. Goto A, Mukai M, Notoya A, Kohno M. Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report. Mod Rheumatol 2005;15(2):118-122. (Pubitemid 40823385)
15. Mustila A, Korpela M, Mustonen J, Helin H, Huhtala H, Soppi E, et al. Perinuclearantineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. Arthritis Rheum 1997;40(4):710-717. (Pubitemid 127744659)
16. Mustila A, Paimela L, Leirisalo-Repo M, Huhtala H, Miettinen A. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease. Arthritis Rheum 2000;43(6):1371-1377. (Pubitemid 30416324)
17. Tur BS, Suldur N, Ataman S, Tutkak H, Atay MB, Duzgun N. Anti-neutrophil cytoplasmic antibodies in patients with rheumatoid arthritis: clinical, biological, and radiological correlations. Joint Bone Spine 2004;71(3):198-202. (Pubitemid 38739129)
18. Bosch X, Llena J, Collado A, Font J, Mirapeix E, Ingelmo M, et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. J Rheumatol 1995;22(11):2038-2045.
19. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B, et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005;52(12): 4039-4043. (Pubitemid 41798244)
20. Farago B, Talian GC, Komlosi K, Nagy G, Berki T, Gyetvai A, et al. Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatol Int 2009;29(7):793-796.
21. Johansson M, Arlestig L, Hallmans G, Rantapaa-Dahlqvist S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther 2006;8(1):R19.
22. Lee AT, LiW, Liew A, Bombardier C, Weisman M, Massarotti EM, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 2005; 6(2):129-133.
23. Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR, et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66(2):143-150. (Pubitemid 46226045)
24. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, et al. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 2006;54(5):1390-1400.
25. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;363(3):221-232.
26. Watts RA. Vasculitis syndromes: Inducing remission in ANCA-positive vasculitis: time to RAVE? Nat Rev Rheumatol 2010;6(3):127-128.
27. Falk RJ, Jennette JC. Rituximab in ANCA-associated disease. N Engl J Med 2010;363(3):285-286.
28. Gomez-Puerta JA, Quintana LF, Stone JH, Ramos-Casals M, Bosch X. B-cell depleting agents for ANCA vasculitides: A new therapeutic approach. Autoimmun Rev Nov 21 (Epub) 2011.
29. Fervenza FC. Rituximab in ANCA-Associated Vasculitis: Fad or Fact? Nephron Clin Pract 2010;118(2):c182-c1c8.
30. Hinze CH, Colbert RA. B-cell depletion in Wegener's granulomatosis. Clin Rev Allergy Immunol 2008;34(3): 372-379.
31. Chen M, Kallenberg CG. ANCA-associated vasculitides-advances in pathogenesis and treatment. Nat Rev Rheumatol 2010;6(11):653-664.
32. Cartin-Ceba R, Keogh KA, Specks U, Sethi S, Fervenza FC. Rituximab for the treatment of Churg-Strauss syndrome with renal involvement. Nephrol Dial Transplant 2011;26: 2865-2871.
33. Niles J. Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis. Clin ExpImmunol 164 Suppl 1:27-30.